We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

193 hedge funds and large institutions have $3.92B invested in Dyne Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $973K

124% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 21

72% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 46

45% more capital invested

Capital invested by funds: $2.71B → $3.92B (+$1.21B)

40% more funds holding in top 10

Funds holding in top 10: 10 → 14 (+4)

14% more funds holding

Funds holding: 169 → 193 (+24)

3.01% less ownership

Funds ownership: 116.41% → 113.4% (-3%)

Holders
193
Holders Change
+24
Holders Change %
+14.2%
% of All Funds
2.79%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.2%
New
47
Increased
79
Reduced
46
Closed
21
Calls
$6.11M
Puts
$973K
Net Calls
+$5.13M
Net Calls Change
+$11.2M

Top Buyers

1
RI
RTW Investments
New York
+$95.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$61M
3
Holocene Advisors
Holocene Advisors
New York
+$60.3M
4
BlackRock
BlackRock
New York
+$58M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$56.6M

Top Sellers

1
MAM
MPM Asset Management
Massachusetts
-$54.9M
2
LGM
Logos Global Management
California
-$42.6M
3
State Street
State Street
Massachusetts
-$28.8M
4
DTC
Deep Track Capital
Connecticut
-$16.1M
5
NCM
Nantahala Capital Management
Connecticut
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
126
Victory Capital Management
Texas
$676K +$557K +19,152 New
SEI Investments
127
SEI Investments
Pennsylvania
$638K -$184K -6,318 -26%
Aberdeen Group
128
Aberdeen Group
United Kingdom
$631K +$519K +17,869 New
GGHC
129
Gilder Gagnon Howe & Co
New York
$619K +$510K +17,546 New
GCA
130
Genesee Capital Advisors
New York
$577K +$475K +16,359 New
Handelsbanken Fonder
131
Handelsbanken Fonder
Sweden
$561K +$462K +15,900 New
Allianz Asset Management
132
Allianz Asset Management
Germany
$558K +$116K +4,000 +34%
LCM
133
Legato Capital Management
California
$546K +$117K +4,035 +35%
PI
134
PEAK6 Investments
Illinois
$543K +$448K +15,400 New
ProShare Advisors
135
ProShare Advisors
Maryland
$535K -$33K -1,137 -7%
ASRS
136
Arizona State Retirement System
Arizona
$532K +$93K +3,199 +27%
TRCT
137
Tower Research Capital (TRC)
New York
$496K +$392K +13,477 +2,336%
Principal Financial Group
138
Principal Financial Group
Iowa
$486K -$47.4K -1,632 -11%
PFM
139
Privium Fund Management
Netherlands
$486K +$407K +14,016 New
AGM
140
Alpine Global Management
New York
$440K +$362K +12,460 New
Teacher Retirement System of Texas
141
Teacher Retirement System of Texas
Texas
$417K +$64.2K +2,209 +23%
CUAMC
142
China Universal Asset Management Company
China
$406K -$118K -4,075 -26%
Mariner
143
Mariner
Kansas
$387K +$35.6K +1,224 +13%
SO
144
STRS Ohio
Ohio
$374K -$285K -9,800 -48%
BHCM
145
Brevan Howard Capital Management
Jersey
$355K +$292K +10,053 New
Zurich Cantonal Bank
146
Zurich Cantonal Bank
Switzerland
$330K -$610 -21 -0.2%
EFM
147
E Fund Management
China
$312K -$216K -7,446 -46%
AQR Capital Management
148
AQR Capital Management
Connecticut
$300K +$10.2K +352 +4%
FC
149
FORA Capital
Florida
$290K +$239K +8,222 New
Royal Bank of Canada
150
Royal Bank of Canada
Ontario, Canada
$285K +$89.2K +3,069 +61%
4 5
6
7 8

DYN Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2024, worth a combined $3.92B — up 45% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new DYN positions and 21 closed out — a net gain of 26 holders — while 79 added to existing stakes and 46 trimmed.

The largest buyer was RTW Investments, adding an estimated $95.8M. The largest seller was MPM Asset Management, cutting an estimated $54.9M.

  • 193 institutional investors held Dyne Therapeutics (DYN) as of Q2 2024, up from 169 in Q1 2024.
  • Funds reported $3.92B of Dyne Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
  • 47 funds opened new Dyne Therapeutics positions in Q2 2024 and 21 closed out, a net change of +26 holders.
  • The largest Dyne Therapeutics buyer in Q2 2024 was RTW Investments, an estimated $95.8M added.
  • The largest Dyne Therapeutics seller in Q2 2024 was MPM Asset Management, an estimated $54.9M sold.

Based on aggregated 13F filings for Q2 2024.